Navigation Links
ASU receives 2-year, $5.3 million DARPA award to safeguard soldiers from infectious diseases
Date:9/14/2010

Scientists at the Biodesign Institute at Arizona State University have received a 2-year, $5.3 million grant from the Defense Advanced Research Projects Agency (DARPA) to protect warfighters in the event of exposure to infectious diseases during deployment.

Dr. Stephen Albert Johnston and his colleagues at the Biodesign Institute have taken on a daunting test of skill: to develop a potential therapeutic that can protect soldiers against an unknown pathogenand do it in a week.

Any commercially available therapeutic typically requires about a decade or more to go from the benchtop to the marketplace. "Half of this period involves all the research and development of the therapeutic, the chemistry to make it, and so on," said Johnston, director of the Biodesign Institute's Center for Innovations in Medicine. "The other half is all the clinical trials testing and FDA approval." The group's goal will focus on reducing the front end of this processthe research and development phaseto just 7 days.

The DARPA challenge was extended to the research community as part of its Accelerated Critical Therapeutics program, a long-standing initiative in response to emerging and novel biological threats.

Johnston's research team has developed new technologies that could accomplish this seemingly impossible feat, drastically reducing the time necessary to produce a general agent against a disease-causing invader. In addition to benefiting the warfighter, his team's approach, involving the use of synthetic antibodies or synbodies, may ultimately find its way into a broad range of applications of benefit to the general public, including medical diagnostics and vaccine development and validation.

Like their human immune system counterparts, synbodies can chemically sniff out invasive microbes with very high specificity, binding with and neutralizing them. Synbodies against the selected pathogen can then be rapidly produced and stockpiled usi
'/>"/>

Contact: Joe Caspermeyer
joseph.caspermeyer@asu.edu
480-727-0369
Arizona State University
Source:Eurekalert  

Page: 1 2

Related biology news :

1. U of I receives $1 million USDA grant to study Glossy15 in sorghum
2. UCSF receives $15 million to advance personalized medicine
3. Carnegie Mellon receives funding to create new program studying environmental impact of nanotechnology
4. Jefferson receives $3 million NIH grant to study molecular and genetic mechanisms in platelets
5. University of Maryland receives $1.9M from NSF for investigations of biomolecular structure
6. NYU School of Medicine receives $8.2M grant from NIDDK to continue urological disease research
7. University of Maryland School of Medicine receives $7.9 million grant for super research magnet
8. University of Maryland partnership receives $7.9M from NIH for superconducting research magnet
9. Stem cell, artificial liver research receives Coulter Foundation funding at NJIT
10. Case Western Reserve geneticist receives prestigious NIH Directors Pioneer Award
11. UC Riverside receives 6 grants for tobacco-related research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ASU receives 2-year, $5.3 million DARPA award to safeguard soldiers from infectious diseases
(Date:12/17/2014)... , Dec. 16, 2014  Automation is ... this more evident than at international borders. Over ... document scanners have allowed veteran travelers to self ... Passport Control (APC) Kiosks at an increasing number ... globe. According to Maxine ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
(Date:12/10/2014)... 8, 2014 You,ve been here before: you desperately ... remember your password, site key or the answer to your ... grade teacher? Today, Hoyos Labs , ... that will finally put an end to the frustration that ... . 1U leverages a user,s smartphone to acquire his ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... 2013Universit Laval researchers have developed a highly effective method for ... low-emissions fuel for vehicles. The team led by Professor Frdric-Georges ... issue of the Journal of the American Chemical Society ... convert methanol into carbon dioxide in a single step using ...
... of genetically modified mice that Western University scientists call ... run far but they aren,t smart, is furthering the ... Marco Prado and his team at Robarts Research Institute ... of this neurotransmitter becomes available in the brain. ...
... 2013 Based on its recent analysis of the ... with the 2013 European Frost & Sullivan Award for ... originally used for medical point-of-care testing to create an ... test requires only a single-step DNA collection procedure from ...
Cached Biology News:Too green to be true? Researchers develop highly effective method for converting CO2 into methanol 2'Forrest Gump' mice show too much of a good thing, can be bad 2Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 2Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 3Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 4
(Date:12/24/2014)... Md. , Dec. 24, 2014  United ... today that Medtronic, Inc. (NYSE: MDT ... the U.S. Food and Drug Administration (FDA) for ... implantable drug infusion system (including a newly developed ... (treprostinil) Injection delivered intravenously to patients with ...
(Date:12/24/2014)... GMO corn cases filed across the United ... the process of being consolidated in a Kansas federal ... Re: Syngenta AG MIR 162 Corn Litigation, MDL No. ... of Kansas. , Management of the Syngenta GMO corn ... District Judge John W. Lungstrum.* , As a Missouri ...
(Date:12/24/2014)... 2014 The report provides ... its definition, classification, application and industry overview. ... process, and product cost structure. Production is ... analysis also covers upstream raw materials, equipment, ... trend and proposals. In the end, the ...
(Date:12/24/2014)... , Dec. 23, 2014 Vermillion, ... focused on gynecologic disease, announced today that investors ... , Birchview Fund LLC and several Vermillion directors ... unregistered shares of Vermillion,s common stock and warrants ... in a private placement.  Under ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5
... DUBLIN, October 28 , ... EU to Treat,hyperphosphataemia >1.78mmol/L in Chronic Kidney Disease Patients ... (LSE: SHP, NASDAQ: SHPGY ), the global specialty,biopharmaceutical ... Mutual Recognition Procedure for an extension to the current,indication ...
... ... An incident of terrorism, accident, or improper disposal of radioactive ... catastrophe would impact the population with increased cancer and associated illnesses ... distribution network. In response to this threat, Technical Associates created the ...
... Oct. 27 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... authorization in the European Union for rilonacept, an ... Syndromes (CAPS) with severe symptoms, including Familial Cold ... adults and children aged 12 years and older. ...
Cached Biology Technology:Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease 2Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease 3Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease 4Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law 2Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law 3Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law 4Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 2Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 3Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 4Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 5Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 6